Back
Protara Therapeutics, Inc. Stock Price Chart
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
49
TARA
Protara Therapeutics, Inc.
Last Price:
$5.48
Seasonality Move:
27.06%
7 Day Trial
ALL ACCESS PASS
$
7
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is moderately bearish and TARA is experiencing selling pressure, which indicates risk of future bearish movement.
Protara Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.86 | Sell |
| 20-day SMA: | 6.45 | Sell |
| 50-day SMA: | 5.66 | Sell |
| 200-day SMA: | 4.03 | Buy |
| 8-day EMA: | 5.89 | Sell |
| 20-day EMA: | 6.02 | Sell |
| 50-day EMA: | 5.17 | Buy |
| 200-day EMA: | 2.34 | Buy |
Protara Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 43.84 | Sell |
| Chaikin Money Flow: | -870765 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.38 - 7.02) | Sell |
| Bollinger Bands (100): | (3.17 - 5.85) | Buy |
Protara Therapeutics, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protara Therapeutics, Inc. Stock
Is Protara Therapeutics, Inc. Stock a Buy?
-
Protara Therapeutics, Inc. share price is 5.50 while TARA 8-day simple moving average is 5.86, which is a Sell signal.
-
The stock price of TARA is 5.50 while Protara Therapeutics, Inc. 20-day SMA is 6.45, which makes it a Sell.
-
Protara Therapeutics, Inc. 50-day simple moving average is 5.66 while TARA share price is 5.50, making it a Sell technically.
-
TARA stock price is 5.50 and Protara Therapeutics, Inc. 200-day simple moving average is 4.03, creating a Buy signal.
TARA Technical Analysis vs Fundamental Analysis
Sell
49
Protara Therapeutics, Inc. (TARA)
is a Sell
Is Protara Therapeutics, Inc. a Buy or a Sell?
-
Protara Therapeutics, Inc. stock is rated a SellThe current Protara Therapeutics, Inc. [TARA] share price is $5.50. The Score for TARA is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Protara Therapeutics, Inc. Stock Info
Market Cap:
212.2M
Price in USD:
5.50
Share Volume:
1.1M
Protara Therapeutics, Inc. 52-Week Range
52-Week High:
7.82
52-Week Low:
2.77
Sell
49
Protara Therapeutics, Inc. (TARA)
is a Sell
Protara Therapeutics, Inc. Share Price Forecast
-
What is the Protara Therapeutics, Inc. stock price today?The Protara Therapeutics, Inc. stock price is 5.50 USD today.
-
Will TARA stock go up or go down?Protara Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Protara Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protara Therapeutics, Inc. is overvalued.
Is Protara Therapeutics, Inc. Stock a Buy?
-
Protara Therapeutics, Inc. share price is 5.50 while TARA 8-day exponential moving average is 5.89, which is a Sell signal.
-
The stock price of TARA is 5.50 while Protara Therapeutics, Inc. 20-day EMA is 6.02, which makes it a Sell.
-
Protara Therapeutics, Inc. 50-day exponential moving average is 5.17 while TARA share price is 5.50, making it a Buy technically.
-
TARA stock price is 5.50 and Protara Therapeutics, Inc. 200-day simple moving average is 2.34, creating a Buy signal.
Fundamental Analysis of Protara Therapeutics, Inc.
Is Protara Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.85 per share, and a decrease next year of $0.10 per share.
Technical Analysis of Protara Therapeutics, Inc.
Should I short Protara Therapeutics, Inc. stock?
-
TARA Moving Average Covergence Divergence (MACD) indicator is 0.09, suggesting Protara Therapeutics, Inc. is a Buy
-
Protara Therapeutics, Inc. Relative Strength Index (RSI) is 43.84, which suggest Protara Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Protara Therapeutics, Inc. is (5.38 - 7.02), which suggest Protara Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Protara Therapeutics, Inc. is (3.17 - 5.85), which suggest Protara Therapeutics, Inc. is a Buy
* Protara Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.